Colin boasts a rich professional background spanning over 15 dynamic years in life sciences consulting, a journey marked by innovation and strategic insight. He and his team sit within the Strategic Advisory group and work with their clients to identify opportunity spaces for new products, quantify and describe product potential, set strategies and tactics to realize product possibilities, and support various marketing activities. His client base is diverse and inclusive of small and mid-size biotechs bringing paradigm-changing products to the areas of oncology, hematology and central nervous system disorders. Prior to his tenure at Trinity, Colin held leadership positions at healthcare-centric organizations including BluePrint Research Group, RG+A and Ipsos.